Skip to main content
Find a Lawyer

all - Opinion Summaries

FILL IN AT LEAST ONE FIELD

Format is YYYYMMDD

Page 8 of 88 Showing Result 71 - 80 of 874
Description Date Docket #

In Re: Ethicon, Inc.

United States Federal Circuit
Intellectual Property, Patent, Drugs & Biotech
In an appeal of a merged inter partes reexamination, the USPTO Patent Trial and Appeal Board's decision affirming the examiner's obviousness rejection...
01/03/2017 2015-1696

Lawton v. Takeda Pharm. Co.

United States First Circuit
Civil Procedure, Drugs & Biotech
In a qui tam action under the False Claims Act (FCA), 31 U.S.C. section 3729 et seq., and the False Claims Acts of 28 different states and the...
11/22/2016 16-1382

Medical Marijuana, Inc. v. ProjectCBD.com

California Court of Appeal
Drugs & Biotech, Commercial Law, Media Law
In a commercial law action, arising out of a dispute between competing producers and intertwined online media outlets connected to the cannabidiol...
11/21/2016 D068523

In re: Nexium Antitrust

United States First Circuit
Class Actions, Drugs & Biotech, Antitrust & Trade Regulation
In an appeal arising from the first pharmaceutical-settlement antitrust action tried before a jury since the Supreme Court's decision in FTC v....
11/21/2016 15-2005

Schueneman v. Arena Pharms., Inc.

United States Ninth Circuit
Class Actions, Securities Law, Drugs & Biotech
In a putative securities class action in connection with defendants' public statements about their weight-loss drug, lorcaserin, the District Court's...
10/26/2016 14-55633

Pasternack v. Lab. Corp.

United States Second Circuit
Injury & Tort Law, Drugs & Biotech
In a negligence suit against drug testing companies for purportedly mishandling a random drug test, the District Court's dismissal of all claims is...
10/06/2016 14-4101-cv

Local 8 IBEW Retirement Plan & Trust v. Vertex Pharms., Inc.

United States First Circuit
Class Actions, Securities Law, Health Law, Drugs & Biotech
In a securities fraud class action complaint brought by past and current employees of a pharmaceutical company that announced interim results of a...
10/03/2016 15-2250

Mylan Pharmaceuticals Inc v. Warner Chilcott Pub. Ltd.

United States Third Circuit
Drugs & Biotech, Antitrust & Trade Regulation
In a suit brought by generic drug manufactures against name-brand drug manufacturers of 'Doryx' the name-brand version of delayed-release doxycycline...
09/28/2016 15-2236

In Re: Modafinil Antitrust Litigation

United States Third Circuit
Class Actions, Drugs & Biotech, Antitrust & Trade Regulation
In a putative class of twenty-two large and sophisticated corporations, most of which have multi-million dollar claims, alleging a global conspiracy...
09/13/2016 15-3475

UCB, Inc. v. Yeda Research and Development Co., Ltd.

United States Federal Circuit
Intellectual Property, Patent, Drugs & Biotech
In an declaratory judgment requesting a declaration that plaintiff's Cimzia brand antibody does not infringe defendant's patent and that such patent...
09/08/2016 2015-1957

Results 71 to 80 of 874

Copied to clipboard